Anticoagulation in pregnant women with prosthetic heart valve - A new approach for therapy

Harefuah

Volumn 142, Issue 7, 2003, Pages 508-511+567

  Marcus Braun, Naama ^a   Segal, David ^a   Merkin, Miri ^a   Wiznitzer, Arnon ^a   Katz, Miriam ^a   Tager, Salis ^a   Ilya, Reuven ^a   Mazor, Moshe ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Heparin; Pregnancy; Thromboembolism; Valve prostheses; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DOSE CALCULATION; EMBRYOPATHY; FEMALE; FETOTOXICITY; HEART VALVE PROSTHESIS; HEPARINIZATION; HUMAN; PRACTICE GUIDELINE; PREGNANCY; RISK ASSESSMENT; THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN; HUMANS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; REOPERATION;

EID: 0042828857     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. De Swiet M, Heart disease in pregnancy, In: de Swiet M, (ed). Medical Disorders of Obstetric Practice. Oxford: Blackwell, 1984, PP 118, 122, 129,
2. Suri V, Sawhney H, Vasishata K & al, Pregnancy following cardiac valve replacement surgery. Int J Gynaecol Obstet, 1999; 64: 239-246.
3. North RA, Sadler L, Stewart AW & al, Long term survival and valve related complications in young women with cardiac valve replacements. Circulation, 1999; 99: 2669-2676.
4. Horstkotte D, Prosthetic valves or tissue valves-a vote for mechanical prostheses. Z Kardiol, 1985; 74: 19-37.
5. Hanania G, Thomas D, Michal PL & al, Pregnancy and prosthetic heart valves: A French cooperative retrospective study of 155 cases. Eur Heart J, 1994; 15: 1651-1658.
6. Chan WS, Anand S & Ginsberg JS, Anticoagulation of pregnant women with heart valves: a systemic review of the literature. Arch Intern Med, 2000; 160: 191-196.
7. Arnaout MS, Kazma H, Khalil A & al, Is there a safe anticoagulation protocol for pregnant women with prosthetic valves? Clin Exp Obstet Gynecol, 1998; 25: 101-104.
8. Elkayan UR, Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol, 1996; 27: 1704-1706.
9. Ginsberg JS, Greer I & Hirsh J, Use of antithrombotic agents during pregnancy. Chest, 2001; 119: 122S-131S.
10. Lev-Ran O, Kramer A, Gurevitch J & al, Low-molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg, 2000; 69: 264-265.
11. Leyh RG, Fischer S, Ruhparwar A & al, Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg, 2002; 21: 577-579.
12. Menger H, Lin AE, Toriello HV & al, Vitamin K deficiency embryopathy: a phenocopy of the warfarin embryopathy due to a disorder of embryonic vitamin K metabolisim. Am J Med Genet, 1997; 72: 129-134.
13. Bajora R, Soorana SR & Contractor SF, Differential binding of warfarin to maternal, fetal and nonpregnant sera and its clinical implications. J Pharm Pharmacol, 1996; 48: 486-491.
14. Mungall D, Ludden TM, Marshall J & al, Relationship between steady-state sodium warfarin concentration and anticoagulant effect. Clin Pharmacokinet, 1984; 9: 99-100.
15. Irollo B, Dang VB, Nguyen DD & al, Dissociation and association rate constants changes following bilirubin binding affinity decreases. Dev Pharmacol Ther, 1987; 10: 436-442,
16. Reverdieu-Moalic P, Delahousse B, Body G & al, Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood, 1996; 88: 900-906.
17. Pauli RM, Lian JB, Masher DF & al, Association of congenital deficiency of multiple vitamin K dependent coagulation factors and the phenotype of sodium warfarin embryopathy-clues to the mechanism of teratogenicity. Am J Hum Genet, 1987; 41: 566-583.
18. Vitale N, De Feo M, De Santo LS & al, Dose dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol, 1999; 33: 1637-1641.
19. Cotrufo M, De Feo M, De Santo LS & al, Risk of Warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol, 2002; 99: 35-40.
20. th ed. Philadelphia, U.S.A, W.B Standers company, 1997, pp 568-569.
21. th ed. Philadelphia, U.S.A, W.B Standers company, 2001, pp 2172-2191.